Source: iQoncept / Shutterstock
Cerevel Therapeutics Hldg (NASDAQ:CERE) just reported results for the second quarter of 2024.
- Cerevel Therapeutics Hldg reported earnings per share of -73 cents. This was below the analyst estimate for EPS of -61 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/cere-stock-earnings-cerevel-therapeutics-hldg-for-q2-of-2024/.
©2024 InvestorPlace Media, LLC